ARCT
Arcturus Therapeutics Holdings
$12.07
+$0.84 (+7.48%)Oct 28, 2026
Key metrics
The numbers that frame ARCT today
- Market cap
- $343.07M
- Gross margin
- 100%
- EV / Sales
- 5.8
- ROIC
- -375.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $5.50
- 52wk High
- $17.96
Growth
Revenue and earnings trend for ARCT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARCT
Is Arcturus Therapeutics Holdings a good buy?
Yes. Arcturus Therapeutics Holdings has excellent momentum, and it outweighs the weak quality here. Growth looks strong, which supports the long-term business case. We think Arcturus Therapeutics Holdings is selling at a very high price, which cuts against the buy case.
What is the market capitalization of ARCT?
Arcturus Therapeutics Holdings's market capitalization is $343.07M.
What is the 52-week high for ARCT stock?
The 52-week high for Arcturus Therapeutics Holdings is $17.96. The current close of $12.07 is 32.8% below that high.
What is the 52-week low for ARCT stock?
The 52-week low for Arcturus Therapeutics Holdings is $5.50. The current close of $12.07 is 119.5% above that low.
Does ARCT stock pay dividends?
Arcturus Therapeutics Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ARCT?
Arcturus Therapeutics Holdings's Debt / Equity ratio is 0.11.